-
-
-
-
-
-
-
Acelyrin (SLRN) Phase 2b/3 trial of izokibep did not meet primary endpoint
-
-
-
-
-
-
-
Jefferies Starts Acelyrin Inc (SLRN) at Buy; ' More than a HS story'
-
14,665 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

